Pontifax Management 4 G.P., 10% Owner of Keros Therapeutics KROS, has filed 1 purchase and 4 sales on the open market. Over the past 12 months that comes to a net sale of $85M. The latest trade was on 25/10/15.

PG

PG

Pontifax Management 4 G.P.

10% Owner

Company

Keros Therapeutics KROS

First filing

25/09/16

Trades

7 trades

Buys / sales

1 / 4

12-month net buying

−$85M

Last trade

25/10/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Keros TherapeuticsKROS	Open-market sale	25/10/15	25/10/17	4,787,331 sh4 trades	$17.75avg.	$84,975,125.25	−100.0%
LB PharmaceuticalsLBRX	Open-market buy	25/09/12	25/09/16	1,000,000 sh	$15.00	$15,000,000	+242.9%